Targeting PD-1/PD-L1 interactions for cancer immunotherapy

被引：296
|
作者：
Zitvogel, Laurence [1 ,2 ,3 ,4 ]
Kroemer, Guido [3 ,5 ,6 ,7 ,8 ]
机构：
[1] Inst Gustave Roussy, INSERM, U1015, F-94805 Villejuif, France
[2] Inst Gustave Roussy, Ctr Clin Invest CBT507, Villejuif, France
[3] Inst Gustave Roussy, Villejuif, France
[4] Univ Paris 11, Villejuif, France
[5] INSERM, U848, Villejuif, France
[6] Ctr Rech Cordeliers, Paris, France
[7] Hop Europeen Georges Pompidou, Paris, France
[8] Univ Paris 05, Fac Med, Paris, France
来源：
ONCOIMMUNOLOGY | 2012年 / 1卷 / 08期
关键词：
CELL CARCINOMA PATIENTS; CLINICAL-SIGNIFICANCE; PD-1; PATHWAY; B7-H1; EXPRESSION; MOLECULE; IMMUNOSUPPRESSION; RECEPTORS; LIGAND-1; ANTIBODY;
D O I：
10.4161/onci.21335
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1223 / 1225
页数：3
相关论文
共 50 条
  • [1] PD-1/PD-L1 and immunotherapy for pancreatic cancer
    Feng, Mengyu
    Xiong, Guangbing
    Cao, Zhe
    Yang, Gang
    Zheng, Suli
    Song, Xujun
    You, Lei
    Zheng, Lianfang
    Zhang, Taiping
    Zhao, Yupei
    CANCER LETTERS, 2017, 407 : 57 - 65
  • [2] PD-L1/PD-1 blockade in breast cancer: The immunotherapy era
    Li, Chia-Jung
    Lin, Li-Te
    Hou, Ming-Feng
    Chu, Pei-Yi
    ONCOLOGY REPORTS, 2021, 45 (01) : 5 - 12
  • [3] Contemporary clinical trials in pancreatic cancer immunotherapy targeting PD-1 and PD-L1
    Nagaraju, Ganji Purnachandra
    Malla, Rama Rao
    Basha, Riyaz
    Motofei, Ion G.
    SEMINARS IN CANCER BIOLOGY, 2022, 86 : 616 - 621
  • [4] Divergent Expression of PD-1 as Challenges and Chances of Immunotherapy Targeting PD-1 or PD-L1 in Cancer
    Huang, Haozhe
    BIOINFORMATICS AND BIOMEDICAL ENGINEERING, PT II, IWBBIO 2024, 2024, 14849 : 55 - 69
  • [5] Targeting PD-1/PD-L1 in tumor immunotherapy: Mechanisms and interactions with host growth regulatory pathways
    Shen, Songyu
    Hong, Yihan
    Huang, Jiajun
    Qu, Xiaosheng
    Sooranna, Suren Rao
    Lu, Sheng
    Li, Tian
    Niu, Bing
    CYTOKINE & GROWTH FACTOR REVIEWS, 2024, 79 : 16 - 28
  • [6] Immunotherapy in Breast Cancer: the Emerging Role of PD-1 and PD-L1
    Bertucci, Francois
    Goncalves, Anthony
    CURRENT ONCOLOGY REPORTS, 2017, 19 (10)
  • [7] Peptide Blocking of PD-1/PD-L1 Interaction for Cancer Immunotherapy
    Li, Chunlin
    Zhang, Nengpan
    Zhou, Jundong
    Ding, Chen
    Jin, Yaqing
    Cui, Xueyuan
    Pu, Kefeng
    Zhu, Yimin
    CANCER IMMUNOLOGY RESEARCH, 2018, 6 (02) : 178 - 188
  • [8] PD-1/PD-L1 blockade: Prospectives for immunotherapy in cancer and autoimmunity
    Hosseinzadeh, Ramin
    Feizisani, Fahimeh
    Shomali, Navid
    Abdelbasset, Walid Kamal
    Hemmatzadeh, Maryam
    Gholizadeh Navashenaq, Jamshid
    Jadidi-Niaragh, Farhad
    Bokov, Dmitry O.
    Janebifam, Morteza
    Mohammadi, Hamed
    IUBMB LIFE, 2021, 73 (11) : 1293 - 1306
  • [9] Intelligent delivery system targeting PD-1/PD-L1 pathway for cancer immunotherapy
    Liu, Ning
    Zhang, Renshuai
    Shi, Qiang
    Jiang, Hongfei
    Zhou, Qihui
    BIOORGANIC CHEMISTRY, 2023, 136
  • [10] Clinical evaluation of compounds targeting PD-1/PD-L1 pathway for cancer immunotherapy
    Lu, Jing
    Lee-Gabel, Linda
    Nadeau, Michelle C.
    Ferencz, Thomas M.
    Soefje, Scott A.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2015, 21 (06) : 451 - 467
12345